July 2013

The latest from Cogstate, leaders in optimizing the measurement of cognition

New Data Demonstrated Cognigram as a Useful Tool in Assessing Cognitive Function

July 17, 2013

This week at the Alzheimer’s Association International Conference in Boston, Merck is highlighting a new study showing the effectiveness of using Cognigram™ in the general medicine setting to assist with ongoing monitoring of cognitive decline and diagnosis of dementia and related diseases. Cognigram™ is a computer-based system designed to measure and monitor cognitive function for neuro-degenerative […]

Australian research sheds new light on “highest risk” group for Alzheimer’s disease

July 17, 2013

ASX Announcement BRR Webcast – Australian research sheds new light on “highest risk” group for Alzheimer’s disease MELBOURNE, 17 July 2013: Professor Paul Maruff, Chief Science Officer at Melbourne-based cognition testing company Cogstate, explains the findings of four reports presented at the Alzheimer’s Association International Conference (AAIC) in a video interview with Boardroom Radio (BRR). […]

Cogstate Science Team Presentation Schedule for AAIC 2013

July 13, 2013

Cogstate’s team of scientists will be very active at the Alzheimer’s Association International Conference, AAIC 2013, providing their latest research updates throughout the week in Boston. Cogstate Presentations at AAIC 2013 Presenter: Yen Lim (oral presentation) Time: Sun, 14th July 2:15 – 3:45pm Notes: Diagnosis and Prognosis: Neuropsychological Associations with Amyloid Imaging and APOE Presentation Number: […]

Cogstate Releases New Alzheimer’s Research at AAIC 2013 – An Interview With Dr. Paul Maruff

July 12, 2013

As the last of the “Baby Boomer” generation reaches their 50th birthday, they are faced with mixed news about their future health.  While the incidence of heart disease and cancer, the top two leading causes of death, have been on a downward slope over the last decade, Alzheimer’s disease, the fifth most common cause, now […]